The proliferative invasive capacities of glioblastoma cells in vivo were significantly attenuated in mice with Ahsg knockdown compared to control mice (injected with scrambled shRNA-transfected LN229 cells) [31]. The gene discussed is AHSG; the disease is glioblastoma.